[go: up one dir, main page]

NO844815L - Sphingosinderivater, deres fremstilling og farmasoeytiske tilberedning - Google Patents

Sphingosinderivater, deres fremstilling og farmasoeytiske tilberedning

Info

Publication number
NO844815L
NO844815L NO844815A NO844815A NO844815L NO 844815 L NO844815 L NO 844815L NO 844815 A NO844815 A NO 844815A NO 844815 A NO844815 A NO 844815A NO 844815 L NO844815 L NO 844815L
Authority
NO
Norway
Prior art keywords
formula
acid
compound
compounds
acyl residue
Prior art date
Application number
NO844815A
Other languages
English (en)
Norwegian (no)
Inventor
Roland Tschannen
Wolfgang Fraefel
Richard Robert Schmidt
Rudolf Klaeger
Peter Zimmermann
Original Assignee
Solco Basel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6493/83A external-priority patent/CH679209A5/de
Application filed by Solco Basel Ag filed Critical Solco Basel Ag
Publication of NO844815L publication Critical patent/NO844815L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO844815A 1983-12-05 1984-12-03 Sphingosinderivater, deres fremstilling og farmasoeytiske tilberedning NO844815L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6493/83A CH679209A5 (en) 1983-12-05 1983-12-05 New neutral glyco-sphingolipid derivs.
CH467184 1984-09-28

Publications (1)

Publication Number Publication Date
NO844815L true NO844815L (no) 1985-06-06

Family

ID=25696036

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844815A NO844815L (no) 1983-12-05 1984-12-03 Sphingosinderivater, deres fremstilling og farmasoeytiske tilberedning

Country Status (11)

Country Link
US (1) US4952683A (es)
EP (1) EP0146810A3 (es)
AU (1) AU570087B2 (es)
CA (1) CA1259610A (es)
DK (1) DK573384A (es)
ES (2) ES8604986A1 (es)
FI (1) FI844775L (es)
HU (1) HU195516B (es)
NO (1) NO844815L (es)
PL (1) PL143901B1 (es)
YU (2) YU202784A (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
DE3683214D1 (de) * 1985-08-13 1992-02-13 Solco Basel Ag Neues verfahren zur herstellung von sphingosinderivaten.
US4769362A (en) * 1985-10-01 1988-09-06 Trustees Of Boston University Increased vascular perfusion following administration of lipids
JPH07116209B2 (ja) * 1986-04-11 1995-12-13 メクト株式会社 シアロシルセラミド類及びその製造方法
EP0255717A3 (en) * 1986-08-06 1990-12-05 Mect Corporation Ganglioside related compounds and method of producing the same
EP0299201A3 (de) * 1987-06-12 1990-08-22 Wilhelm Dr. Hoerrmann Fett-Aminoalkohol enthaltendes Arzneimittel
ES2065343T3 (es) * 1987-06-26 1995-02-16 Solco Basel Ag Nuevos preparados farmaceuticos asi como nuevos compuestos de lactosilo y su preparacion.
US4957741A (en) * 1988-08-02 1990-09-18 Angio-Medical Corp. Method for the treatment of gastric ulcer
US5066496A (en) * 1988-08-03 1991-11-19 Angio-Medical Corporation Composition and method for treatment of gastric and duodenal ulcers and mucosal erosions
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
DE3916072A1 (de) * 1989-05-17 1990-11-22 Thera Ges Fuer Patente Ceramidderivate und ihre verwendung als inhibitoren der sphingolipidsynthese
DE4102817A1 (de) * 1991-01-31 1992-08-06 Merck Patent Gmbh Verfahren zur stereoselektiven herstellung von (beta)-fucopyranosyl-phosphaten und sehr reiner gdp-fucose
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (es) * 1992-07-16 1995-11-01 Kirin Brewery
JP3717512B2 (ja) * 1992-10-22 2005-11-16 麒麟麦酒株式会社 新規スフィンゴ糖脂質およびその使用
US5780441A (en) * 1993-04-15 1998-07-14 Kirin Beer Kabushiki Kaisha Sphingoglycolipid compounds and therapeutic uses thereof
WO1995003028A1 (en) * 1993-07-23 1995-02-02 Morris Herstein Cosmetic, skin-renewal stimulating composition with long-term irritation control
US5663151A (en) * 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5686426A (en) * 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
WO1996023523A1 (en) * 1995-02-03 1996-08-08 Korea Institute Of Science And Technology Novel hemostatic composition
DK0869185T5 (da) 1997-03-03 2004-11-29 Sumitomo Chemical Co Fremstilling af en optisk aktiv sphingoid-forbindelse
WO2000017216A1 (fr) 1998-09-21 2000-03-30 Otsuka Pharmaceutical Co., Ltd. Derives de carboxymethylgalactose
US20040180852A1 (en) * 2003-03-10 2004-09-16 Cara-Lynne Schengrund Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus
DE102004025000A1 (de) * 2004-05-21 2005-12-08 Bayer Technology Services Gmbh Verfahren zur Herstellung von chemischen und pharmazeutischen Produkten mit integrierter Mehrsäulen-Chromatographie
CN101460458A (zh) 2006-02-15 2009-06-17 阿勒根公司 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
US8097644B2 (en) * 2006-03-28 2012-01-17 Allergan, Inc. Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist
JP5564672B2 (ja) * 2006-06-30 2014-07-30 ザ スクリプス リサーチ インスティテュート アジュバント及びその使用方法
US8524917B2 (en) * 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
EP2125723A1 (en) 2007-01-11 2009-12-02 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
EP2203424A1 (en) * 2007-09-24 2010-07-07 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
US8143291B2 (en) 2008-05-09 2012-03-27 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
CA2733970A1 (en) * 2008-08-12 2010-02-18 Allergan, Inc. Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof
US20120088800A1 (en) 2009-06-30 2012-04-12 Allergan, Inc. 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS
US8168795B2 (en) * 2009-08-11 2012-05-01 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
WO2011028927A1 (en) 2009-09-04 2011-03-10 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
MX2012003718A (es) 2009-09-29 2012-06-28 Allergan Inc Compuestos de piridina de anillo condensado como moduladores selectivos de subtipo de receptores de esfingosina-1-fosfato-2 (s1p2).
WO2011066179A1 (en) * 2009-11-24 2011-06-03 Allergan, Inc. Novel compounds as receptor modulators with therapeutic utility
US8741875B2 (en) 2009-11-24 2014-06-03 Allergan, Inc. Compounds as receptor modulators with therapeutic utility
KR20130143091A (ko) 2010-11-22 2013-12-30 알러간, 인코포레이티드 치료적 유용성을 가지는 수용체 조절제로서의 신규한 화합물
EP3842443B1 (en) 2013-03-15 2025-02-19 Cerenis Therapeutics Holding SA Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
WO2022158993A1 (en) 2021-01-25 2022-07-28 Carbocode S.A. Method for the production of d-erythro-sphingosine and analogs thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1495548A (en) * 1974-04-16 1977-12-21 Tate & Lyle Ltd Sugar derivative containing vinyl groups and copolymers thereof
US4362720A (en) * 1977-04-14 1982-12-07 Chembiomed Ltd. Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals

Also Published As

Publication number Publication date
FI844775A7 (fi) 1985-06-06
FI844775A0 (fi) 1984-12-04
HUT36833A (en) 1985-10-28
YU202784A (en) 1987-02-28
EP0146810A3 (de) 1987-05-13
DK573384D0 (da) 1984-12-03
CA1259610A (en) 1989-09-19
ES548901A0 (es) 1986-04-16
YU189686A (en) 1987-12-31
FI844775L (fi) 1985-06-06
PL143901B1 (en) 1988-03-31
AU570087B2 (en) 1988-03-03
ES538231A0 (es) 1986-03-16
AU3628684A (en) 1985-06-13
PL250710A1 (en) 1985-07-16
HU195516B (en) 1988-05-30
ES8606373A1 (es) 1986-04-16
EP0146810A2 (de) 1985-07-03
US4952683A (en) 1990-08-28
ES8604986A1 (es) 1986-03-16
DK573384A (da) 1985-06-06

Similar Documents

Publication Publication Date Title
NO844815L (no) Sphingosinderivater, deres fremstilling og farmasoeytiske tilberedning
US5936076A (en) αgalactosylceramide derivatives
US5220043A (en) Synthesis of D-erythro-sphingomyelins
Xia et al. Synthesis and biological evaluation of α-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3)
EP0609437B1 (en) Novel sphingoglycolipid and use thereof
Hanahan et al. Potent platelet stimulating activity of enantiomers of acetyl glyceryl ether phosphorylcholine and its methoxy analogues
AU728637B2 (en) Inositolglycans having insulin-like action
DE10128250A1 (de) Neue Glykolipidderivate
Yano et al. Total synthesis of Myc-IV (C16: 0, S) via automated electrochemical assembly
Zhang et al. Synthetic tetra-acylated derivatives of lipid A from Porphyromonas gingivalis are antagonists of human TLR4
EP0489162A1 (en) Derivative of glycolipid containing sialic acid
NO173873B (no) Analogifremgangsmaate til fremstilling av en terapeutisk aktiv monosakkaridforbindelse
US4730058A (en) Sialosylceramides and production method thereof
FI82058B (fi) Nytt foerfarande foer framstaellning av sfingocinderivat.
Jiang et al. Monophosphoryl lipid A analogues with varying 3-O-substitution: synthesis and potent adjuvant activity
EP0204344B1 (en) Sialosylcerebrosides and a preparation method thereof
Gigg The allyl ether as a protecting group in carbohydrate chemistry. Part 10. Synthesis of 3-O-(β-D-galactopyranosyl 3-sulphate)-2-O-hexadecanoyl-1-O-hexadecyl-L-glycerol,‘seminolipid’
Chigorno et al. Isolation and characterization of a tetrasialoganglioside from mouse brain, containing 9-O-acetyl, N-acetylneuraminic acid
Ghosal et al. Phosphatidylpyrrolophenanthridine alkaloids from Zephyranthes flava
Weiss et al. Novel method for the synthesis of cholesteryl glucosides starting from disaccharides
DD232052A5 (de) Verfahren zur herstellung von spingosinderivaten
US5380829A (en) Thioglycoside analogs of gangliosides
Hay et al. The partial synthesis of some naturally occurring glycosphingolipids with special reference to 0-β-D-galactosyl-(1→ 4)-0-β-D-galactosyl-(1→ 1)-ceramide
Gorantla et al. Total synthesis of ceramides and β-O-glucosylceramides via intramolecular fatty acyl group migration
Jozwiak et al. Lipid composition of the secretion from human bronchial explant culture